May CPI and Housing...
Health Care: Drugs
Infinity Pharmaceuticals Inc. (INFI: NASDAQ)
$19.46 2.29 | 13.34%
06/18/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 47.11M | 92.77M | 71.33M | 49.54M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 47.11M | 92.77M | 71.33M | 49.54M |
| Selling, General, and Administrative Expenses | 27.88M | 22.72M | 21.07M | 19.46M |
| Research & Development | 118.60M | 108.58M | 99.23M | 77.86M |
| Operating Income before D & A (EBITDA) | -99.36M | -38.53M | -48.97M | -47.77M |
| Depreciation & Amortization | 3.30M | 4.70M | 5.41M | 3.58M |
| Interest Income | 559.00K | 326.75K | 463.01K | 2.04M |
| Other Income - Net | 46.75M | 0.00 | 733.44K | 14.20M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -55.35M | -42.91M | -53.19M | -35.12M |
| Interest Expense | 1.91M | 1.84M | 1.91M | 1.30M |
| Pre-Tax Income | -57.26M | -44.75M | -55.10M | -36.42M |
| Income Taxes | 0.00 | 0.00 | -700.32K | -329.57K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -53.96M | -40.04M | -48.98M | -32.51M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -53.96M | -40.04M | -48.98M | -32.51M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -53.96M | -40.04M | -48.98M | -32.51M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-53.96M | -40.04M | -48.98M | -32.51M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -53.96M | -40.04M | -48.98M | -32.51M |
| Basic EPS from Continuing Ops. | -1.70 | -1.50 | -1.86 | -1.25 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.70 | -1.50 | -1.86 | -1.25 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.70 | -1.50 | -1.86 | -1.25 |
| Basic Normalized Net Income/Share | -1.70 | -1.50 | -1.86 | -1.25 |
| EPS fr Continuing Ops. | -1.70 | -1.50 | -1.86 | -1.25 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.70 | -1.50 | -1.86 | -1.25 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.70 | -1.50 | -1.86 | -1.25 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.70 | -1.50 | -1.86 | -1.25 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with INFI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- Contributor8 Health Care Stocks With R...
Latest INFI Headlines from TheStreet
- Top Insider Trades: NAV, TXI, INFI, AGCO 04.17.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galena 12.07.12 | 07:12 am
- The Next Big Thing In Biotech: ASH Meeting
12.07.12 | 06:12 am - 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 3 Unusual-Volume Stocks Trending Higher 09.12.12 | 02:09 pm
- 5 Earnings Short-Squeeze Plays 08.06.12 | 10:08 am
Press Releases for INFI
- Infinity To Present At The 25th Annual Roth Conference - Business Wire 03.11.13 | 08:03 am
- Infinity Provides Company Update And Reports Full-Year 2012 Financial Results - Business Wire 03.05.13 | 04:03 pm
- Infinity To Present At Upcoming Conferences - Business Wire 02.25.13 | 08:02 am
- Infinity Announces The Date Of Its Full-Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.19.13 | 08:02 am
- Infinity To Participate In Three Conferences In February - Business Wire 02.06.13 | 08:02 am
- Infinity Provides Key 2013 Goals And Financial Guidance - Business Wire 01.07.13 | 08:01 am
- Infinity To Present At The J.P. Morgan Annual Healthcare Conference - Business Wire 12.31.12 | 08:12 am
- Infinity Amends PI3K-Delta,Gamma Agreement With Millennium - Business Wire 12.24.12 | 08:12 am
- Infinity Announces Closing Of Public Offering And Exercise Of Over-Allotment Option - Business Wire 12.18.12 | 10:12 am
- Infinity Prices Public Offering Of Common Stock - Business Wire 12.13.12 | 09:12 am
Partner Headlines for INFI
- Mid-Day Market Update: Stocks Pare Gains, G-III Apparel Surges On Q1 Results - Benzinga 06.04.13 | 01:06 pm
- Pre-Market Most Active for Jun 4, 2013 : ET, ING, NOK, ZNGA, ASML, BAC, UBS, MTU, RIGL, GRFS, QQQ, INFI - NASDAQ 06.04.13 | 12:06 pm
- Social Networking Stocks Faltering And The Volatile Biotechs - Seeking Alpha 06.04.13 | 09:06 am
- Mixed Response on Infinity Pharma as Shares Plunge Amid Phase I Data - Benzinga 06.03.13 | 01:06 pm
- Afternoon Market Losers - Benzinga 06.03.13 | 01:06 pm
- Morning Market Losers - Benzinga 06.03.13 | 09:06 am
- Infinity Presents Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO - Benzinga 06.02.13 | 09:06 am
- Market Wrap for Wednesday, May 22: Stocks Pullback As Bernanke Says Bond Buying Could Slow - Benzinga 05.22.13 | 04:05 pm
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- These Stocks Are On Winning Streaks, But Short Sellers Aren't Optimistic - Seeking Alpha 01.09.13 | 09:01 am
